InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
63,111.04
(
-0.42%
)
Post# of 29598
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biotech_researcher post# 17991

Sunday, 02/10/2019 4:15:30 PM

Sunday, February 10, 2019 4:15:30 PM

Post# of 29598
ELAN—One of the main arguments of the MF article (written in Oct 2018) is that it was hard to gauge Elanco’s financial performance based on historical financial data as a subsidiary of LLY. But this is no longer as pressing an issue now that ELAN has been spun off and its own (standalone) 4Q18 financials are available.

Moreover, ELAN’s share price has declined by about 15% since the MF article was written, making the valuation considerably more reasonable.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up